Mechanism of heterosubtypic immunity to influenza A virus infection

International Congress Series

Volumn 1219, Issue C, 2001, Pages 333-340

  Nguyen, Huan H ^a   van Ginkel, Frederik W ^a   Vu, Huong L ^a   McGhee, Jerry R ^a   Mestecky, Jiri ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Heterosubtypic immunity; Influenza virus; Knockout mice

Indexed keywords

EID: 0442304577     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00344-2     Document Type: Article

References (34)

1. Simonson, L., Schonberger, L.B., Stroup, D.F., Arden, N.H., Cox, N.J., The impact of influenza on mortality in the USA. Brown, L.E., Hampson, A.W., Webster, R.G., (eds.) Options for the Control of Influenza III, 1996, Elsevier, Amsterdam, 26–33.
2. Webster, R.G., Askonas, B.A., Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10 (1980), 396–401.
3. Schulman, J.L., Kilbourne, E.D., Induction of partial specific heterotypic immunity in mice by a single infection with influenza virus. J. Bacteriol. 89 (1965), 170–174.
4. Taylor, P.M., Davey, J., Howland, K., Rothbard, J.B., Askonas, B.A., Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics 26 (1987), 267–272.
5. Townsend, A.R.M., McMichael, A.J., Carter, N.P., Huddleston, J.A., Brownlee, G.G., Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 9 (1984), 13–25.
6. Wraith, D.C., Vessey, A.E., Askonas, B.A., Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68 (1987), 433–440.
7. Yewdell, J.W., Bennink, J.R., Smith, G.L., Moss, B., Influenza virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 82 (1985), 1785–1789.
8. Fu, T.M., Guan, L., Friedman, A., Schofield, T.L., Ulmer, J.B., Liu, M.A., Donnelly, J.J., Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 162 (1999), 4163–4170.
9. Lin, Y.L., Askonas, B.A., Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J. Exp. Med. 154 (1981), 225–234.
10. Lukacher, A.E., Braciale, V.L., Braciale, T.J., In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160 (1984), 814–826.
11. Taylor, P.M., Askonas, B.A., Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58 (1986), 417–420.
12. Wells, M.A., Daniel, S., Djeu, J.Y., Kiley, S.C., Ennis, F.A., Recovery from a viral respiratory tract infection: IV. Specificity of protection by cytotoxic T lymphocytes. J. Immunol. 130 (1983), 2908–2914.
13. Yap, K.L., Ada, G.L., McKenzie, I.F., Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273 (1978), 238–239.
14. Nguyen, H.H., Moldoveanu, Z., Novak, M.J., van Ginkel, F.W., Ban, E., Kiyono, H., McGhee, J.R., Mestecky, J., Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254 (1999), 50–60.
15. Lawson, C.M., Bennink, J.R., Restifo, N.P., Yewdell, J.W., Murphy, B.R., Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 68 (1994), 3505–3511.
16. Liang, S., Mozdzanowska, K., Palladino, G., Gerhard, W., Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152 (1994), 1653–1661.
17. Bender, B.S., Bell, W.E., Taylor, S., Small, P.A. Jr, Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J. Infect. Dis. 170 (1994), 1195–1200.
18. Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R., Doherty, P.C., Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174 (1991), 875–880.
19. Epstein, S.L., Lo, C.Y., Misplon, J.A., Lawson, C.M., Hendrickson, B.A., Max, E.E., Subbarao, K., Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta 2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158 (1997), 1222–1230.
20. Nguyen, H.H., van Ginkel, F.W., Vu, H.L., McGhee, J.R., Mestecky, J., Heterosubtypic immunity to Influenza A virus infection requires B cells, but not CD8+ cytotoxic T lymphocytes (CTL). J. Infect. Dis. 183 (2001), 368–376.
21. Gerhard, W., Mozdzanowska, K., Furchner, M., The nature of heterosubtypic immunity. Brown, L.E., Hampson, A.W., Webster, R.G., (eds.) Options or the Control of Influenza III, 1996, Elsevier, Amsterdam, 235–243.
22. Mozdzanowska, K., Maiese, K., Furchner, M., Gerhard, W., Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 254 (1999), 138–146.
23. Epstein, S.L., Lo, C.Y., Misplon, J.A., Bennink, J.R., Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160 (1998), 322–327.
24. Graham, M.B., Braciale, T.J., Influenza virus clearance in B lymphocyte deficient mice. Brown, L.E., Hampson, A.W., Webster, R.G., (eds.) Options for the Control of Influenza III, 1996, Elsevier, Amsterdam, 166–169.
25. Graham, M.B., Braciale, T.J., Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186 (1997), 2063–2068.
26. Mozdzanowska, K., Furchner, M., Washko, G., Mozdzanowski, J., Gerhard, W., A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71 (1997), 4347–4355.
27. Mozdzanowska, K., Furchner, M., Maiese, K., Gerhard, W., CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239 (1997), 217–225.
28. Topham, D.J., Doherty, P.C., Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J. Virol. 72 (1998), 882–885.
29. Doherty, P.C., Topham, D.J., Tripp, R.A., Cardin, R.D., Brooks, J.W., Stevenson, P.G., Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159 (1997), 105–117.
30. Nguyen, H.H., van Ginkel, F.W., Vu, H.L., Novak, M.J., McGhee, J.R., Mestecky, J., IFN-gamma is not required for mucosal cytotoxic T lymphocyte responses or heterosubtypic immunity (HSI) to influenza A virus infection. J. Virol. 74 (2000), 5495–5501.
31. Qin, D., Wu, J., Vora, K.A., Ravetch, J.V., Szakal, A.K., Manser, T., Tew, J.G., Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J. Immunol. 164 (2000), 6268–6275.
32. Yap, K.L., Ada, G.L., Cytotoxic T cells in the lungs of mice infected with influenza A virus. Scand. J. Immunol. 7 (1978), 73–80.
33. Doherty, P.C., Allan, W., Eichelberger, M., Carding, S.R., Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10 (1992), 123–1151.
34. Yetter, R.A., Lehrer, S., Ramphal, R., Small, P.A.J., Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29 (1980), 654–662.